Atlantic Union Bankshares’s Novo Nordisk NVO Stock Holding History

Atlantic Union Bankshares’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$552K	Buy	15,027 +235	+2%	+$11.1K	0.01%	447
2025 Q4	$753K	Buy	14,792 +93	+0.6%	+$4.76K	0.01%	414
2025 Q3	$816K	Buy	14,699 +11,881	+422%	+$695K	0.02%	411
2025 Q2	$195K	Buy	+2,818	New	+$192K	﹤0.01%	479
2014 Q2	–	Sell	-80	Closed	-$7K	–	195
2014 Q1	$7K	Buy	+80	New	+$1.7K	﹤0.01%	219

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Atlantic Union Bankshares's NVO Position: Q1 2026 in Review

Atlantic Union Bankshares increased its Novo Nordisk (NVO) stake by 1.6% in Q1 2026, buying an estimated $11.1K and bringing the position to 15,027 shares worth $552K. The position accounts for 0.01% of the portfolio, ranked #447.

Atlantic Union Bankshares first reported a position in NVO in Q1 2014 and has held it in 5 quarters since. The position peaked at $816K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Atlantic Union Bankshares held 15,027 shares of Novo Nordisk worth $552K as of Q1 2026.
Atlantic Union Bankshares bought 235 Novo Nordisk shares in Q1 2026, an estimated $11.1K.
Novo Nordisk made up 0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #447 holding.
Atlantic Union Bankshares first reported a position in Novo Nordisk in Q1 2014 and has held it in 5 quarters since.
Atlantic Union Bankshares's Novo Nordisk position peaked at $816K in Q3 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.